Laboratoires NEGMA
Quick facts
Marketed products
- Diacerhein · Other
Phase 3 pipeline
- ART 44 · Infectious Diseases
ART 44 is an antiretroviral drug used to treat HIV-1 infection. - ART 50 · Infectious Diseases
ART 50 is an antiretroviral medication used to treat HIV-1 infection.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: